Following confirmation of low serum T levels and concomitant signs and symptoms of hypogonadism, clinicians should use serum LH and FSH in conjunction with testosterone to differentiate between primary and secondary hypogonadism. This evidence concerns the gene BRD2 and hypogonadotropic hypogonadism.